Jennifer N Brudno

Jennifer N Brudno

UNVERIFIED PROFILE

Are you Jennifer N Brudno?   Register this Author

Register author
Jennifer N Brudno

Jennifer N Brudno

Publications by authors named "Jennifer N Brudno"

Are you Jennifer N Brudno?   Register this Author

7Publications

323Reads

47Profile Views

Recent advances in CAR T-cell toxicity: Mechanisms, manifestations and management.

Blood Rev 2019 03 14;34:45-55. Epub 2018 Nov 14.

Experimental Transplantation and Immunology Branch, National Cancer Institute, Building 10, Suite 3-3330, Bethesda, MD 20892, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.blre.2018.11.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628697PMC
March 2019

T Cells Genetically Modified to Express an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma.

J Clin Oncol 2018 08 29;36(22):2267-2280. Epub 2018 May 29.

Jennifer N. Brudno, Irina Maric, Steven D. Hartman, Jeremy J. Rose, Norris Lam, Maryalice Stetler-Stevenson, Dalia Salem, Constance Yuan, Steven Pavletic, Jennifer A. Kanakry, Lekha Mikkilineni, Steven A. Feldman, David F. Stroncek, Brenna G. Hansen, Rashmika Patel, Frances Hakim, Ronald E. Gress, and James N. Kochenderfer, National Institutes of Health, Bethesda; Syed Abbas Ali, Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center, Baltimore; Judith Lawrence, Leidos Biomedical Research, Frederick, MD; Michael Wang, University of Texas MD Anderson Cancer Center, Houston, TX; and Dalia Salem, Mansoura University, Mansoura, Egypt.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2018.77.8084
Publisher Site
http://dx.doi.org/10.1200/JCO.2018.77.8084DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6067798PMC
August 2018

Chimeric antigen receptor T-cell therapies for lymphoma.

Nat Rev Clin Oncol 2018 Jan 31;15(1):31-46. Epub 2017 Aug 31.

Experimental Transplantation and Immunology Branch, National Cancer Institute, NIH Building 10 room 3-3330, Bethesda, Maryland 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2017.128DOI Listing
January 2018

Toxicities of chimeric antigen receptor T cells: recognition and management.

Blood 2016 06 20;127(26):3321-30. Epub 2016 May 20.

Experimental Transplantation and Immunology Branch, National Cancer Institute, Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2016-04-703751DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4929924PMC
June 2016

Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host Disease.

J Clin Oncol 2016 Apr 25;34(10):1112-21. Epub 2016 Jan 25.

Jennifer N. Brudno, Robert P.T. Somerville, Victoria Shi, Jeremy J. Rose, David C. Halverson, Daniel H. Fowler, Juan C. Gea-Banacloche, Steven Z. Pavletic, Dennis D. Hickstein, Tangying L. Lu, Steven A. Feldman, Alexander T. Iwamoto, Brenna G. Hansen, Bazetta Blacklock-Schuver, Frances T. Hakim, Steven A. Rosenberg, Ronald E. Gress, and James N. Kochenderfer, National Cancer Institute; Roger Kurlander and Irina Maric, National Institutes of Health, Bethesda; Jennifer S. Wilder, Frederick National Laboratory for Cancer Research, Frederick, MD; and Andre Goy, John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.64.5929DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872017PMC
April 2016